Skip to content
Nine Square Therapeutics

Nine Square Therapeutics

This company develops small molecules to upregulate autophagy to treat Parkinson’s disease. 

Autophagy is the process which cells use to break down waste materials (like accumulating proteins) or damaged cell organelles (like damaged mitochondria). 

In Parkinson’s disease, autophagy is dysregulated, leading to accumulation of proteins in brain cells (like alpha-synuclein), and the piling up of damaged mitochondria (given they are not properly cleared via autophagy). 

Cart 0

Your cart is currently empty.

Start Shopping